Insights.
Distributed Drug Manufacturing
Last week I mentioned, I've been obsessing over generic drug manufacturing.
This isn't an out-of-the-blue Karl Schmieder obsession. I've worked on communications projects for biopharma manufacturers and, for about a decade, have written about quality control issues associated with foreign manufacturers.